Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04773457 · ClinicalTrials.gov registry record
Neutrophil Phenotypic Profiling and Surgical Site Infections in Surgical Patients
A clinical trial of Surgical Site Infection, sponsored by Boston Children's Hospital.
- Active
- Registry status
- 220
- Enrollment target
- 1
- Study location
NCT04773457: Active study of Surgical Site Infection, sponsored by Boston Children's Hospital.
NCT04773457 is a study of Surgical Site Infection that is active but no longer recruiting, run by Boston Children's Hospital. The registered enrollment target is 220 participants, below the 560-participant average among 25 other Surgical Site Infection trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04773457, a study of Surgical Site Infection, is active but no longer recruiting, sponsored by Boston Children's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 220 participants
- Enrollment target
- 1
- Study location
Study Summary
Surgical site infections (SSIs) are one of the major hospital acquired infections and responsible for the most cost among the hospital acquired infections. The objective of this study is to assess the neutrophil functional profiles and their associations with SSIs.
Primary Outcome
compare neutrophil population between patients with SSI and without SSI by delineating transcriptomic profiles
Conditions Studied
Interventions
- OTHER Surgical Site Infection
Study Locations (1)
Massachusetts
- Boston Children's Hopsital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2024-02-01 |
| Est. Completion | 2026-12-01 |
What the registry record for NCT04773457 still lists
NCT04773457 is an observational study that tracks outcomes without assigning an intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, below the 560-participant average among 25 other Surgical Site Infection trials with a reported enrollment target (61% lower).
The record links to 1 condition, with Surgical Site Infection appearing as the primary indexed condition, and to 1 intervention - of which Surgical Site Infection is the first listed.
NCT04773457 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04773457 about?
NCT04773457 is a clinical study titled "Neutrophil Phenotypic Profiling and Surgical Site Infections in Surgical Patients". Surgical site infections (SSIs) are one of the major hospital acquired infections and responsible for the most cost among the hospital acquired infections. The objective of this study is to assess the neutrophil functional profiles and their associations with SSIs.
What is the current status of trial NCT04773457?
This trial is currently active not recruiting. The enrollment target is 220 participants. The study started on 2024-02-01. Estimated completion is 2026-12-01.
What conditions does trial NCT04773457 study?
This clinical trial studies the following conditions: Surgical Site Infection.
What interventions are being tested in trial NCT04773457?
The interventions under investigation include: Surgical Site Infection (OTHER).
Who is sponsoring clinical trial NCT04773457?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04773457 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgical Site Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04773457's enrollment target sits among peer trials
220 15th of 25 higher than 11 of 25 other Surgical Site Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Surgical Site Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Zinc Oxide Versus Petrolatum Following Skin Surgery
RECRUITING · Early Phase 1
-
Diluted Aqueous Povidone-Iodine Compared to Saline to Decrease Surgical Site Infections
RECRUITING · Phase 3
-
Decolonization to Reduce After-Surgery Events of Surgical Site Infection
RECRUITING · Phase 4
-
Studying How Outpatient Water affEcts Risks With Drains (SHOWER Study)
RECRUITING · NA
-
A Novel Surgical Irrigation Solution in Post-Mastectomy Reconstruction: Evaluating Xperience™
RECRUITING · NA
-
Ostomy Primary Closure With 0.1% Betaine/Polyhexanide Wound Irrigation Compared to Pursestring Closure
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00920972 · 220 participants · Phase 1
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- NCT01851642 · 220 participants
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
- NCT02582021 · 220 participants
WISE CVD - Continuation (WISE HFpEF)
- NCT04067830 · 220 participants · Phase 2
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI